rs141950826
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_000426.4(LAMA2):āc.5291A>Gā(p.Glu1764Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000119 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA2 | ENST00000421865.3 | c.5291A>G | p.Glu1764Gly | missense_variant | 37/65 | 5 | NM_000426.4 | ENSP00000400365.2 | ||
LAMA2 | ENST00000618192.5 | c.5555A>G | p.Glu1852Gly | missense_variant | 38/66 | 5 | ENSP00000480802.2 | |||
LAMA2 | ENST00000617695.5 | c.5291A>G | p.Glu1764Gly | missense_variant | 37/64 | 5 | ENSP00000481744.2 | |||
LAMA2 | ENST00000687590.1 | n.1711A>G | non_coding_transcript_exon_variant | 5/5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250960Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135672
GnomAD4 exome AF: 0.000114 AC: 167AN: 1461680Hom.: 0 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727136
GnomAD4 genome AF: 0.000164 AC: 25AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74398
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 22, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | LAMA2: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 10, 2020 | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 01, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2023 | The c.5291A>G (p.E1764G) alteration is located in exon 37 (coding exon 37) of the LAMA2 gene. This alteration results from a A to G substitution at nucleotide position 5291, causing the glutamic acid (E) at amino acid position 1764 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
LAMA2-related muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at